IOL Chemicals and Pharmaceuticals has secured Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Health Care (EDQM) for its API product ‘CLOPIDOGREL BESILATE’ on February 23, 2026. The company has an existing valid CEP for ‘CLOPIDOGREL BISULPHATE.’ Clopidogrel is an antiplatelet medication used in the treatment and prevention of cardiovascular diseases.
IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.
